Neuronetics (STIM) Long-Term Investments (2019 - 2026)
Neuronetics' (STIM) quarterly Long-Term Investments came in at $108000.0 in Q1 2026, up 45.95% year-on-year from $74000.0 in Q1 2025, and up 10.2% on a QoQ basis from $98000.0 in Q4 2025.
Neuronetics (STIM) Long-Term Investments (2019 - 2026) Analysis & Trends
Neuronetics (STIM) has 8 years of Long-Term Investments data on file, last reported at $108000.0 in Q1 2026.
- On a quarterly basis, Long-Term Investments rose 45.95% year-over-year to $108000.0 in Q1 2026; TTM through Mar 2026 was $108000.0, a 45.95% increase from a year earlier, with the FY2025 full-year figure at $98000.0, up 13.95% from the prior year.
- Long-Term Investments for Q1 2026 stood at $108000.0, up from $98000.0 in the prior quarter.
- Over the last five years, Long-Term Investments for STIM reached as high as $1.7 million in Q2 2022 and fell as low as $74000.0 in Q1 2025.
- Historically, Long-Term Investments has averaged $622764.7 across 5 years, with a median of $517000.0 in 2024.
- Across the five-year window, Long-Term Investments plunged 86.99% in 2024 and surged 45.95% in 2026, its largest moves.
- Year by year, Long-Term Investments stood at $1.2 million in 2022, then sank by 45.91% to $661000.0 in 2023, then slumped by 86.99% to $86000.0 in 2024, then rose by 13.95% to $98000.0 in 2025, then increased by 10.2% to $108000.0 in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $108000.0 in Q1 2026, $98000.0 in Q4 2025, and $94000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 98,000.00 |
| Sep 30, 2025 | 94,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Sep 30, 2024 | 140,000.00 |
| Jun 30, 2024 | 268,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Dec 31, 2023 | 661,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 859,000.00 |
| Mar 31, 2023 | 989,000.00 |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | 1.70 Mn |
| Sep 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 1.85 Mn |